Nanomerics is developing a range of products focused on particular areas for which there is a large unmet medical need. This includes nose-to-brain administration, as well as specific ocular and oral products. 

​

Nanomerics has successfully developed and then out-licensed and partnered products but is also working with partners on the application of its technologies to overcome particular delivery challenges.

​

A recent innovation is our Molecular Mask Technology (MMT) which makes an important contribution to the fight against Sars-Cov2 and other viral pandemics by providing a 'one puff' spray mask that reduces the risk of infections by up to 10,000-fold and which is expected to be active against all variants.

​

In addition, some of Nanomerics' technologies have application to non-pharmaceutical applications where enhanced activity and precise delivery of actives are required.